tiprankstipranks
Advertisement
Advertisement
Racura taps Purdue expertise to decode MYC-silencing mechanism of (E,E)-bisantrene
PremiumCompany AnnouncementsRacura taps Purdue expertise to decode MYC-silencing mechanism of (E,E)-bisantrene
10d ago
Racura showcases oncology pipeline at inaugural R&D investor symposium
Premium
Company Announcements
Racura showcases oncology pipeline at inaugural R&D investor symposium
12d ago
Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares
Premium
Company Announcements
Racura Oncology Seeks ASX Quotation for Additional Ordinary Shares
17d ago
Racura Oncology to List 22,554 New Shares on ASX
PremiumCompany AnnouncementsRacura Oncology to List 22,554 New Shares on ASX
1M ago
Racura Oncology to Showcase Bisantrene Strategy at Investor R&D Symposium
Premium
Company Announcements
Racura Oncology to Showcase Bisantrene Strategy at Investor R&D Symposium
1M ago
Racura Oncology Plans Investor Briefings in Hong Kong and Singapore
Premium
Company Announcements
Racura Oncology Plans Investor Briefings in Hong Kong and Singapore
1M ago
Racura Oncology Seeks ASX Quotation for 23,047 New Ordinary Shares
PremiumCompany AnnouncementsRacura Oncology Seeks ASX Quotation for 23,047 New Ordinary Shares
2M ago
Racura Oncology Seeks ASX Quotation for 141,645 New Shares
Premium
Company Announcements
Racura Oncology Seeks ASX Quotation for 141,645 New Shares
2M ago
Racura Oncology Secures Key Bisantrene Patent Filings, Expands RC220 Clinical Programs and Bolsters Cash Position
Premium
Company Announcements
Racura Oncology Secures Key Bisantrene Patent Filings, Expands RC220 Clinical Programs and Bolsters Cash Position
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100